Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a novel RNA virus from the betacoronavirus family. Members of the coronavirus family have adapted to human hosts and effectively get ...

(MENAFN- GlobeNewsWire - Nasdaq) Newark, New Castle, USA, June 13, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global hypercoagulability treatment market was conducted by Growth Plus Reports ...

Background: There is growing evidence that cardiovascular diseases are relatively more prevalent in subjects who feel anxious. An increased clotting diathesis might subject anxious individuals to an ...

NEWARK, Del, Feb. 13, 2023 (GLOBE NEWSWIRE) -- The global hypercoagulability treatment market is predicted to generate a market value of US$ 670 million in 2023 and a market value of US$ 1,317.99 ...

TYPE 2 diabetes means the body doesn't use insulin properly - a hormone which regulates a person's blood sugar levels. Without proper treatment, toxic amounts of sugar can build up in the bloodstream, ...

Incidence of thrombotic complications in patients with COVID-19 who are critically ill is high, with an estimated incidence of 31% for arterial or venous thromboembolism (VTE), acute pulmonary ...

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), is characterized by a range of clinical presentations. The vascular ...

The largest sample size (2,200 cases) pooled analysis of LT-PCR achieving quantitative determination of folate receptor-positive CTCs for lung cancer in China. Correlation of AR-V7 expression in whole ...

Leesburg, VA, September 24, 2020--According to an open-access article in ARRS' American Journal of Roentgenology (AJR), because coronavirus disease (COVID-19) may present with medium to large arterial ...

The global hypercoagulability treatment market is expected to garner a market value of US$ 670 million in 2023 and is expected to accumulate a market value of US$ 1,317.99 million by registering a ...